Showing 5191-5200 of 9772 results for "".
- BTL Takes a Stand Against Illegal and Counterfeit Aesthetic Deviceshttps://practicaldermatology.com/news/btl-takes-a-stand-against-illegal-and-counterfeit-aesthetic-devices/2461593/BTL is making inroads in its efforts to safeguard medical providers and consumers from counterfeit devices in the United States through legal action and the seizure of illegally imported devices at the border. BTL has filed court documents stating that defendants use and sell knock
- Fewer Cases of Melanoma, Cancers in Extracutaneous Sites Seen in Patients with Atopyhttps://practicaldermatology.com/news/fewer-cases-of-melanoma-cancers-in-extracutaneous-sites-seen-in-patients-with-atopy/2461591/Fewer cases of melanoma are observed in people with a history of atopic diseases, such as allergic asthma or rhinitis, than in nonatopic people, according to a new study in Melanoma Research. Specifically, the risk of melanoma in people with atopy was up to 50% lower than
- Landmark Data: Neoadjuvant Pembrolizumab Improves Outcomes for High-risk Melanoma Patientshttps://practicaldermatology.com/news/landmark-data-neoadjuvant-pembrolizumab-improves-outcomes-for-high-risk-melanoma-patients/2461589/Patients with high-risk melanoma who received pembrolizumab both before and after surgery had a significantly lower risk of their cancer recurring than patients who received the drug only after surgery. These results, published today in the
- Merz Aesthetics Taps Christina Aguilera as New Xeomin Brand Partnerhttps://practicaldermatology.com/news/merz-aesthetics-taps-christina-aguilera-as-new-xeomin-brand-partner/2461588/Christina Aguilera is the latest Xeomin (incobotulinumtoxinA) brand partner as Merz Aesthetics expands its ‘Beauty on Your Terms’ marketing campaign. Launched in August 2022, the campaign features multiple music icons in support of Xeomin.
- Cetaphil Unveils Digital AI Skin Analysis Toolhttps://practicaldermatology.com/news/cetaphil-unveils-digital-ai-skin-analysis-tool/2461587/Cetaphil is launching Cetaphil AI Skin Analysis, a comprehensive skin analyzer off
- Bristol Myers Squibb Advances Melanoma Drug Candidate Opdivo in US and Europehttps://practicaldermatology.com/news/bristol-myers-squibb-advances-melanoma-drug-candidate-opdivo-in-us-and-europe/2461583/Bristol Myers Squibb announced that the FDA has accepted the supplemental Biologics License Application (BLA) for Opdivo (nivolumab) as monotherapy in the adjuvant setting for the treatment of patients with completely resected stage IIB or IIC melanoma. The company also announced t
- Study: Plugging Immune Cell Leakage from Tumors Could Improve MelanomaTreatmenthttps://practicaldermatology.com/news/study-plugging-immune-cell-leakage-from-tumors-could-improve-melanomatreatment/2461578/The number of specialized immune cells available for fighting skin cancer double when a new treatment blocks their escape from melanoma tumors, according to new research out of NYU Langone Health’s Perlmutter Cancer Center Combining a chemical blocker of immune cell exit with
- Biomarkers May Predict AD Developmenthttps://practicaldermatology.com/news/biomarkers-may-predict-ad-development/2461575/An immune and lipid profile on the surface of the skin of infants may predict the development of atopic dermatitis months before the onset of illness. “The holy grail to deal with atopic dermatitis is to prevent it,” says study author
- Study: Psoriasis Medicine May Help Treat Alcohol Use Disorderhttps://practicaldermatology.com/news/psoriasis-medicine-may-help-treat-alcohol-use-diisorder/2461571/Apremilast may be an “incredibly promising” treatment for alcohol use disorder, according to a new study in the Journal of Clinical Investigation. On average, the people who took apremi
- Celluma Light Therapy Headquarters Moves to Tustin, Californiahttps://practicaldermatology.com/news/celluma-light-therapy-headquarters-moves-to-tustin-calif/2461570/BioPhotas, Inc., the maker of the Celluma Series of light therapy devices, is moving its corporate headquarters and manufacturing operations from Anaheim to Tustin, Calif. The new headquarters boasts 25,000 square feet of office and warehouse space, facilitating continued gro